ABVC · ABVC BioPharma Inc
United States · RS rating 15 · As of 2026-10-14
| Price | 1.02 USD |
|---|---|
| 1-day change | +4.2% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 38 / 24 / 9 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 23 / 26 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +50.0% |
| Sales growth Q/Q | +100.0% |
| Distance from 52-week high | +66.0% |
| Market cap (USD) | $29.2M |